Questcor Pharmaceuticals (QCOR) Jumps Higher on Analyst Defense

July 13, 2012 2:00 PM EDT
Questcor Pharmaceuticals (Nasdaq: QCOR) is bouncing again on word analysts at BofA have confirmed that the company threatening to develop a generic form of ACTH is fraudulent.

While still down 3.4 percent, these comments are moving shares higher - something the earlier company JMP presentation was unable to do.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Trader Talk

Related Entities

Bank of America

Add Your Comment